Medical Developments International Limited
MDDVF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $19,069 | $19,987 | $18,067 | $15,082 |
| % Growth | -4.6% | 10.6% | 19.8% | – |
| Cost of Goods Sold | $4,361 | $5,268 | $15,115 | $20,534 |
| Gross Profit | $14,708 | $14,719 | $2,952 | -$5,452 |
| % Margin | 77.1% | 73.6% | 16.3% | -36.1% |
| R&D Expenses | $271 | $0 | $313 | $0 |
| G&A Expenses | $12,075 | $10,064 | $26,382 | $6,163 |
| SG&A Expenses | $14,063 | $12,020 | $27,820 | $7,547 |
| Sales & Mktg Exp. | $1,988 | $1,956 | $1,438 | $1,384 |
| Other Operating Expenses | $0 | $0 | -$21,313 | $0 |
| Operating Expenses | $14,334 | $12,020 | $6,820 | $7,547 |
| Operating Income | $374 | $2,699 | -$3,868 | -$12,999 |
| % Margin | 2% | 13.5% | -21.4% | -86.2% |
| Other Income/Exp. Net | -$523 | -$2,382 | -$16,274 | $215 |
| Pre-Tax Income | -$149 | $317 | -$20,142 | -$12,784 |
| Tax Expense | $61 | $13 | $9,905 | -$1,839 |
| Net Income | -$210 | $304 | -$30,047 | -$10,945 |
| % Margin | -1.1% | 1.5% | -166.3% | -72.6% |
| EPS | -0.002 | 0.003 | -0.34 | -0.12 |
| % Growth | -170.4% | 100.8% | -183.3% | – |
| EPS Diluted | -0.002 | 0.003 | -0.34 | -0.12 |
| Weighted Avg Shares Out | 110,410 | 112,593 | 88,602 | 88,602 |
| Weighted Avg Shares Out Dil | 112,615 | 112,576 | 88,602 | 88,602 |
| Supplemental Information | – | – | – | – |
| Interest Income | $167 | $135 | $143 | $259 |
| Interest Expense | $0 | $0 | $42 | $44 |
| Depreciation & Amortization | -$64 | $1,597 | $1,868 | $1,526 |
| EBITDA | -$1,025 | $2,699 | -$18,232 | -$11,214 |
| % Margin | -5.4% | 13.5% | -100.9% | -74.4% |